Long-term review of a breast conservation series and patterns of care over 18 years

ANZ Journal of Surgery

Volumn 73, Issue 8, 2003, Pages 577-583

  Pendlebury, Susan C ^a   Ivanov, Olga ^a   Renwick, Stuart ^a   Stevens, Graham N ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Breast cancer; Breast conservation; Chemotherapy; Endocrine therapy; Radiation therapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; HORMONE;

ADULT; AGE; AGED; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL LITERATURE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PREDICTION; PUBLICATION; REVIEW; STANDARD; SURVIVAL RATE; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROFESSIONAL PRACTICE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0041854230     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2003.t01-1-02704.x     Document Type: Review

References (53)

1. Fisher B, Bauer M, Margolese R et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N. Engl. J. Med. 1985; 312: 665-8.
2. Veronesi U, Banff A, Salvadori B et al. Breast conservation is the treatment of choice in small breast cancer: Long term results of a randomised clinical trial. Eur. J. Cancer 1990; 26: 668-70.
3. van Dongen J, Bartelink H, Fentimen I et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. Monogr. Natl Cancer Inst. 1992; 11: 15-18.
4. Blichert-Toft M, Brincker H, Andersen J et al. A Danish randomized trial comparing breast preservation therapy with mastectomy in mammary carcinoma. Acta Oncol. 1988; 27: 671-6.
5. Lichter A, Lippman M, Danforth D et al. Mastectomy versus breast conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial in the National Cancer Institute. J. Clin. Oncol. 1992; 10: 976-83.
6. Sarrazin D, Le M, Arriagada R et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother. Oncol. 1989; 14: 177-84.
7. Simes RJ, Kearsley J, Donovan J. Conservative surgery and radiotherapy as primary treatment for early breast cancer: Results of a 10 year experience. Australas. Radiol. 1983; 27: 50-7.
8. National Health and Medical Research Council (Australia). Clinical Practice Guidelines for the Management of Early Breast Cancer. Canberra: NHMRC National Breast Cancer Centre, 1995.
9. Canadian Medical Association. Clinical practice guidelines for the care and treatment of breast cancer. Can. Med. Assoc. J. 1998; 158.
10. Royal College of Radiologists Clinical Oncology Information Network. Guidelines for the non-surgical management of breast cancer. Clin. Oncol. 1999; 11.
11. Clark RM, McCulloch PB, Levine MN et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J. Natl Cancer Inst. 1992; 84: 683-9.
12. Whelan T, Clark R, Roberts R, Levine M, Foster G. Ipsilateral breast tumor recurrence post lumpectomy is predictive of subsequent mortality: Results from a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 1994; 30: 11-16.
13. Lilegren G, Holmberg L, Adami H-O, Westman G, Graffman S, Bergh J. Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five-year results of a randomized trial. J. Natl Cancer Inst. 1994; 86: 717-22.
14. Veronesi U, Luini A, Del Vecchio M et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N. Engl. J. Med. 1993; 328: 1587-91.
15. Early Breast Cancer Trialists Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N. Engl. J. Med. 1995; 333: 1444-55.
16. Hill D, Jamrozik K, White V et al. Surgical Management of Breast Cancer in Australia in 1995. Canberra: NHMRC National Breast Cancer Centre, 1999.
17. NSW Breast Cancer Institute. Surgical Management of Breast Cancer in Australia in 1995: NSW Results. Canberra: NSW Breast Cancer Institute, 2000.
18. van Dongen J, Voogd A, Fentimen I et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and treatment of Cancer 10801 trial. J. Natl Cancer Inst. 2000; 92: 1143-50.
19. Amalric R, Santamaria F, Robert F et al. Radiation therapy with or without primary limited surgery for operable breast cancer: 20-year experience at the Marseilles Cancer Institute. Cancer 1982; 49: 30-4.
20. Calle R, Vilcoq J, Zafrani B, Vielh P, Fourquet A. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1986; 12: 873-8.
21. Danoff B, Pajak T, Solin L, Goodman R. Excisional biopsy, axillary node dissection and definitive radiotherapy for stages I and II breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11: 479-83.
22. Osborne M, Ormiston N, Harmer C, McKinna J, Baker J, Greening P. Breast conservation in the treatment of early breast cancer. A 20-year follow up. Cancer 1984; 53: 349-55.
23. Forrest P, Stewart H, Everingham D, Prescott R, McArdle C, Harnett A. Randomized controlled trial of conservation therapy for breast cancer: Six-year analysis of the Scottish trial. Lancet 1996; 348: 708-13.
24. Boyages J, Bosch C, Langlands A, Bilous M, Barraclough B, Gebski V. Breast conservation: Long-term Australian data. Int. J. Radiat. Oncol. Biol. Phys. 1992; 24: 253-60.
25. Burke M-F, Allison R, Tripcony L. Conservation therapy of breast cancer in Queensland. Int. J. Radiat. Oncol. Biol. Phys. 1995; 31: 295-303.
26. Boyages J, Langlands A. Post-mastectomy radiation therapy: Better late than never. Aust. N.Z. J. Surg. 1998; 68: 550-3.
27. Voogt A, Nielsen M, Peterse J et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J. Clin. Oncol. 2001; 19: 1688-97.
28. Kim S, Simkovich-Heerdt A, Tran K, Maclean B, Borges P. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J. Am. Coll. Surg. 1998; 187: 111-18.
29. Recht A, Connolly J, Shnitt S et al. The effects of young age on tumour recurrence in the treated breast after conservative surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1988; 14: 3-10.
30. Delouche G, Bachelor F, premont M, Kurtz J. conservation treatment of early breast cancer: Long term results and complications. Int. J. Radiat. Oncol. Biol. Phys. 1987; 13: 29-34.
31. Fourquet A, Campana F, Zafrani B et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int. J. Radiat. Oncol. Biol. Phys. 1989; 17: 719-25.
32. Kurtz J, Spitalier J, Amalric R et al. Mammary recurrences in women younger than forty. Int. J. Radiat. Oncol. Biol. Phys. 1988; 15: 271-6.
33. Nobler M, Venet L. Prognostic factors in patients undergoing curative irradiation for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11: 1323-31.
34. van Limbergen E, van den Bogaet W, van der Schueren E, Rijnders A. Tumour excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother. Oncol. 1987; 8: 1-9.
35. Solin L, Fowble B, Schultz D, Goodman, R. Age as a prognostic indicator for patients treated with definitive irradiation for early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16: 373-81.
36. Sauer R, Schauer H, Rauschecker M et al. Therapy of small breast cancer: A prospective study based on 1036 patients with special emphasis on prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 1992; 23: 907-14.
37. Boyages J, Recht A, Connolly J et al. Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother. Oncol. 1990; 19: 29-41.
38. Vicini F, Eberlein T, Connolly J et al. Extent of resection for patients with stage I-II breast cancer treated with conservative surgery and radiotherapy. Ann. Surg. 1991; 214: 200-5.
39. Clarke R, Le M, Sarrazm D et al. Analysis of loco-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustav-Roussy. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11: 137-45.
40. Early Breast Cancer Trialsis Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 1-15.
41. Early Breast Cancer Trialists Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 71-85.
42. Early Breast Cancer Trialists Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 1998; 351: 1451-67.
43. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey PC. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J. Clin. Oncol. 1988; 6: 1107-17.
44. Fisher B, Perera F, Cooke A et al. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: An indication for radiotherapy? Int. J. Radiat. Oncol. Biol. Phys. 1997; 38: 551-9.
45. Cusick J, Stewart H, Peto R et al. Overview of randomized trials in postoperative adjuvant radiotherapy in breast cancer. Recent Results Cancer Res. 1988; 111: 108-29.
46. Cusick J, Stewart H, Rutquist L et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J. Clin. Oncol. 1994; 12: 447-53.
47. Yamada Y, Ackerman I, Franssen E, MacKenzie R, Thomas G. Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int. J. Radiat. Oncol. Biol. Phys. 1999; 44: 99-104.
48. Slotman B, Meyer O, Njo K, Karim A. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother. Oncol. 1994; 13: 206-12.
49. Buchholz T, Austin-Seymour M, Moe R et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1993; 26: 23-35.
50. Recht A, Come S, Henderson I et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early stage breast cancer. N. Engl. J. Med. 1996; 334: 1356-61.
51. Fisher B, Brown A, Dimitrov A et al. Two months of doxorubicin-cyclophosphamide with and without internal reduction therapy compared with six months of cyclophosphamide, methotrexate and fluorouracil in positive-node breast cancer patients with Tamoxifen non-responsive tumours: Results from the National Surgical Adjuvant Breast and Bone Project B-15. J. Clin. Oncol. 1990; 8: 1483-96.
52. Wallgren A, Bernier J, Roncadin M et al. Timing of radiotherapy and chemotherapy following breast conserving surgery for patients with node-positive breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1996; 35: 649-58.
53. Bonnadonna G, Brusamolino E, Valagussa P et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N. Engl. J. Med. 1976; 294: 405-10.